Welcome to CDC stacks | Macrolide-Resistant Mycoplasma pneumoniae in Humans, Ontario, Canada, 2010–2011 - 20879 | Emerging Infectious Diseases
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Macrolide-Resistant Mycoplasma pneumoniae in Humans, Ontario, Canada, 2010–2011
  • Published Date:
    2013
  • Source:
    Emerg Infect Dis. 19(9):1525-1527.
Filetype[PDF-376.90 KB]


Details:
No Related Documents.
You May Also Like:
  1. Macrolide-Resistant Mycoplasma pneumoniae, United States1
    Personal Author:
    Zheng, Xiaotian; Lee, Stella; Selvarangan, Rangaraj; Qin, Xuan; Tang, Yi-Wei; Stiles, Jeffrey; Hong, Tao; Todd, Kathleen; Ratliff, Amy E.; Crabb, Donna M.; Xiao, Li; Atkinson, T. Prescott; Waites, Ken B.;
    Published:
    Aug 2015
    Source:
    Emerg Infect Dis. 21(8):1470-1472.
    Description:
    Macrolide-resistant Mycoplasma pneumoniae (MRMP) is highly prevalent in Asia and is now being reported from Europe. Few data on MRMP are available in the United States. Using genotypic and phenotypic methods, we detected high-level MRMP in 13.2% of 9...
    File Type:
    Filetype[PDF - 574.09 KB]
  2. Risk for Emergence of Dengue and Chikungunya Virus in Israel
    Personal Author:
    Leshem, Eyal; Bin, Hanna; Shalom, Uri; Perkin, Maayan; Schwartz, Eli;
    Published:
    Feb 2012
    Source:
    Emerg Infect Dis. 18(2):345-347.
    File Type:
    Filetype[PDF - 147.41 KB]
  3. The Evolution of Advanced Molecular Diagnostics for the Detection and Characterization of Mycoplasma pneumoniae
    Personal Author:
    Diaz, Maureen H.; Winchell, Jonas M.;
    Published:
    Mar 08 2016
    Source:
    Front Microbiol. 2016; 7.
    Description:
    Over the past decade there have been significant advancements in the methods used for detecting and characterizing Mycoplasma pneumoniae, a common cause of respiratory illness and community-acquired pneumonia worldwide. The repertoire of available mo...
    File Type:
    Filetype[PDF - 904.79 KB]
  4. Mycoplasma pneumoniae and Chlamydia spp. Infection in Community-Acquired Pneumonia, Germany, 2011–2012
    Personal Author:
    Dumke, Roger; Schnee, Christiane; Pletz, Mathias W.; Rupp, Jan; Jacobs, Enno; Sachse, Konrad; Rohde, Gernot; Group, CAPNETZ Study;
    Published:
    Mar 2015
    Source:
    Emerg Infect Dis. 21(3):426-434.
    Description:
    Mycoplasma pneumoniae and Chlamydia spp., which are associated with community-acquired pneumonia (CAP), are difficult to propagate, and can cause clinically indistinguishable disease patterns. During 2011-2012, we used molecular methods to test adult...
    File Type:
    Filetype[PDF - 562.94 KB]
  5. Macrolide Resistance of Mycoplasma pneumoniae, South Korea, 2000–2011
    Personal Author:
    Hong, Ki Bae; Choi, Eun Hwa; Lee, Hoan Jong; Lee, Seong Yeon; Cho, Eun Young; Choi, Jae Hong; Kang, Hyun Mi; Lee, Jina; Ahn, Young Min; Kang, Yeon-Ho; Lee, Joon-Ho;
    Published:
    Aug 2013
    Source:
    Emerg Infect Dis. 19(8):1281-1284.
    Description:
    In Korea, Mycoplasma pneumoniae was detected in 255/2,089 respiratory specimens collected during 2000-2011; 80 isolates carried 23S rRNA gene mutations, and 69/123 culture-positive samples with the mutation were resistant to 5 macrolides. During 2000...
    File Type:
    Filetype[PDF - 508.51 KB]